global Peripheral Vascular Devices market is projected to reach USD 13.4 billion by 2026 from USD 10.3 billion in 2021, at a CAGR of 5.3% from 2021 to 2026. Peripheral vascular devices are used to diagnose and treat peripheral vascular diseases such as coronary artery disease, deep vein thrombosis, and peripheral arterial disease. These devices are also used for the treatment of vascular malformations and varicose veins. Some of the commonly used devices include catheters, angioplasty balloons, stents, embolic coils, and atherectomy devices.
The growth of the peripheral vascular devices market is expected to be driven by the increasing prevalence of peripheral vascular diseases, the rising demand for minimally invasive treatments, and the introduction of novel products. Additionally, the increasing focus on healthcare expenditure and technological advancements are expected to fuel the market growth.
Get a sample of the report: https://www.prnewswire.com/news-releases/peripheral-vascular-devices-market-worth-13-4-billion-by-2026--exclusive-report-by-marketsandmarkets-301440092.html
Top Lading Players: Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Cardinal Health (US), B. Braun Melsungen AG (US), Merit Medical Systems (US), Penumbra, Inc.(US), Koninklijke Philips N.V.( Netherlands), iVascular S.L.U (Spain), Biosensors International Group Ltd. (Singapore), BIOTRONIK (Germany), AMG International GmbH (US), ENDOCOR GmbH (Germany)
Some Key Highlights from the Report:
- The global peripheral vascular devices market was valued at USD 10.3 billion in 2021 and is expected to reach USD 13.4 billion by 2026, growing at a CAGR of 5.3% during the forecast period (2021-2026).
- The increasing prevalence of peripheral vascular diseases (PVD) and changing lifestyle are the major factors driving the growth of the market.
- The introduction of minimally invasive procedures and advanced technological innovations in the field of peripheral vascular devices are expected to fuel market growth.
- The rising awareness regarding the early diagnosis and treatment of PVD is driving the demand for peripheral vascular devices.
- The increasing healthcare expenditure and the growing geriatric population are the other factors driving the growth of the market.
- The Asia Pacific region is expected to witness the highest growth rate during the forecast period, owing to the increasing incidence of PVD, the presence of a large population, and the growing demand for advanced healthcare services in the region.
- The increasing focus on research and development activities, mergers and acquisitions, and collaborations between key players in the market are also expected to fuel market growth.
Ask for Customize Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=790
By Product
- Angioplasty Balloons
- Angioplasty Stents
- Catheters
- Endovascular Aneurysm Repair Stent Grafts
- Inferior Vena Cava Filters
- Plaque Modification Devices
- Hemodynamic Flow Alteration Device Market
Regional Outlook:
- North America (U.S.A., Canada, Mexico)
- Europe (Italy, U.K., Germany, France, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
- Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Questions Addressed in the Report:
- What are the dominating factors that are influencing the growth of the industry?
- In the forecast period, which market segment is expected to rise the most?
- What are the risks and challenges that the industry is facing?
- In the coming years, which area is projected to dominate the market?
- Who are the major players in the market?
- What kind of strategic business plans have they made?
Make and inquire to buy this Report @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=790
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com